Search

everythinglearnresearchcommunity

for

Search:↓

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

ABCG2 protein marks stem-like skin cells in human epidermis.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

IL-18 signaling helps mature Tregs move into the thymus.

HPV8 causes skin cancer by expanding specific skin stem cells.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

B cells can both help and hinder the body's defense against melanoma.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.